Tag: Competition

Displaying 221 - 240 of 2231 results.

Pages

From: Walsh, Kathryn E.Sent: Wednesday, September 30, 2015 9:37 AMTo: [Redacted]Subject: RE: Your VM You’re right – those terms do get used interchangeably sometimes, even though they shouldn’t.  The answer is net sales as you define it below – thanks for clarifying. From: [Redacted]...
From: Gillis, Diana L.Sent: Monday, September 28, 2015 11:38 AMTo: [Redacted]; Walsh, Kathryn E.Subject: RE: Question re: sales in or into the US The sales should be attributed to the US assets. We use a bright line on pass through revenues, and it must be clearly stated.
From: Walsh, Kathryn E.Sent: Friday, September 25, 2015 10:12 AMTo: [Redacted]Cc: Berg, Karen E.Subject: RE: Acquisition of a Foreign Issuer [Redacted]: We agree that as the transaction is currently structured, the acquisition of the 50% interest in the JV is exempt under 802.51...
From: Walsh, Kathryn E.Sent: Friday, September 25, 2015 10:13 AMTo: [Redacted]Cc: Berg, Karen E.Subject: RE: Satellite Question [Redacted]: The new interpretation in the PNPM supersedes the informal interpretation you cite – we will update the informal interpretation accordingly. The...
The Commission filed an administrative complaint alleging that Cabell Huntington Hospital’s proposed acquisition of St. Mary’s Medical Center – two hospitals located three miles apart in Huntington, West Virginia--would create a dominant firm with a near monopoly over general acute...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the National Association of Animal Breeders restrained competition among its respective members through its code of ethics.  
The Federal Trade Commission today authorized action to block Cabell Huntington Hospital’s proposed acquisition of St. Mary’s Medical Center – two hospitals located three miles apart in Huntington, West Virginia.
The Federal Trade Commission filed an amicus brief in the U.S. Court of Appeals for the Seventh Circuit urging the court to reverse a district court decision finding  that the mere sale of large-sized packages to one merchant but not another could violate Section 2(e) of the Robinson-Patman Act.
During an antitrust investigation, we often hear that our concerns fail to account for disruptive forces that will soon emerge and shake up the competitive dynamic in the market in the near future—from an innovative newcomer or from the emergence of a completely new business model. ...
From: Gillis, Diana L.Sent: Tuesday, September 22, 2015 10:01 AMTo: [Redacted]; Walsh, Kathryn E.; Whitehead, NoraSubject: RE: Foreign patent For purposes of the foreign exemptions, that is correct (it is possible there could be US revenues for Item 5, e.g. if a US entity handles the...
Brief of the Federal Trade Commission urging the Seventh Circuit to reverse the district court’s holding that the mere sale of large-sized packages to one merchant but not another could violate Section 2(e) of the Robinson-Patman Act. Section 2(e) forbids sellers from providing...
Mylan N.V. agreed to sell the rights and assets related to seven generic drugs in order to settle FTC charges that its proposed acquisition of Perrigo Company plc would be substantially reduce competition in the markets for those drugs if the merger proceeded as originally proposed...
Mylan N.V. has agreed to sell the rights and assets related to seven generic drugs in order to settle FTC charges that its proposed acquisition of Perrigo Company plc would be anticompetitive.
With a tinge of both nostalgia and anticipation, I am pleased to announce a number of management changes at the Bureau. As you may have heard, Deputy Director Steve Weissman will be returning to private practice shortly. Steve is heading back to Baker Botts, where he will help lead...
Federal Trade Commission staff submitted written comments on the competitive impact of legislative proposals to modify the supervision requirements imposed on Advanced Practice Registered Nurses (APRNs) in South Carolina. The comments are in response to a request from South Carolina State...
The Federal Trade Commission has voted unanimously to dismiss its administrative complaint challenging Steris Corporation’s proposed $1.9 billion acquisition of Synergy Health plc. The FTC had filed a lawsuit in federal court seeking an injunction to prevent the acquisition from going forward...
Following a public comment period, the Federal Trade Commission has approved final orders settling charges that pharmaceutical companies Concordia Pharmaceuticals Inc. and Par Pharmaceutical, Inc. entered into an unlawful agreement not to compete in the sale of generic versions of Kapvay, a...
Notice for request for comments on disgorgement
Proposed Form Changes
Pharma Patent Rules

Pages